Health · 1 sources covering this

STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case

The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/91f1f0ea3cbb958c3b736a1fec85b70cfd843e2b"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Supreme Court backs generic drugmaker in &#8216;skinny labeling&#8217; case"></iframe>

STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case

How 1 sources are covering this

STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case

More from Health

STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial

STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach

STAT+: RFK Jr.’s second year: Vacancies, not vaccines

What will it take to get a vaccine for the Ebola strain driving the current outbreak?

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Supreme Court backs generic drugmaker in &#8216;skinny labeling&#8217; case

More from Health

STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial

STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach

STAT+: RFK Jr.’s second year: Vacancies, not vaccines

What will it take to get a vaccine for the Ebola strain driving the current outbreak?

Reader

Trust & legal

Across the network

STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case